Nuvation Bio Inc (NUVB)

Dec 09, 2025

Nuvation Bio Inc. $NUVB is Omega Fund Management LLC's 4th Largest Position - MarketBeat

Dec 09, 2025

Dec 07, 2025

Nuvation Bio (NUVB) price target increased by 12.48% to 10.65 - MSN

Dec 07, 2025

Dec 06, 2025

Nuvation Bio (NYSE: NUVB) partner taletrectinib added to China's 2025 NRDL - Stock Titan

Dec 06, 2025

Dec 06, 2025

Nuvation Bio (NUVB) Price Target Increased by 12.48% to 10.65 - Nasdaq

Dec 06, 2025

Dec 06, 2025

Tema Etfs LLC Purchases Shares of 139,648 Nuvation Bio Inc. $NUVB - MarketBeat

Dec 06, 2025

Dec 05, 2025

Nuvation Bio Stock Jump Looks Great, But How Secure Is That Gain? - Trefis

Dec 05, 2025

Dec 05, 2025

Nuvation Bio (NUVB) bounces back 12% on impressive clinical trial result - MSN

Dec 05, 2025

Dec 05, 2025

Why Nuvation Bio Inc. Class stock is a strong analyst pickPortfolio Update Report & Verified Momentum Stock Alerts - Newser

Dec 05, 2025

Dec 05, 2025

Cash per share of Nuvation Bio Inc. – NYSE:NUVB - TradingView

Dec 05, 2025

Dec 05, 2025

Will Nuvation Bio Inc. Warrants stock profit from AI boom2025 Risk Factors & Technical Buy Zone Confirmations - Newser

Dec 05, 2025

Dec 04, 2025

Insider Selling: Nuvation Bio (NYSE:NUVB) Insider Sells 150,000 Shares of Stock - MarketBeat

Dec 04, 2025

Dec 04, 2025

Why millennials buy Nuvation Bio Inc. Warrants stockJuly 2025 Summary & Risk Managed Investment Signals - Newser

Dec 04, 2025

Dec 04, 2025

Nuvation Bio (NUVB) Bounces Back 12% on Impressive Clinical Trial Result - Insider Monkey

Dec 04, 2025

Dec 04, 2025

Nuvation Bio (NYSE:NUVB) Stock Price Up 8.9%Still a Buy? - MarketBeat

Dec 04, 2025

Dec 04, 2025

NUVB SEC FilingsNuvation Bio Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Dec 04, 2025

Dec 04, 2025

Nuvation Bio’s chief medical officer sells $1.17 million in stock By Investing.com - Investing.com South Africa

Dec 04, 2025

Dec 04, 2025

Nuvation Bio (NYSE:NUVB) Hits New 1-Year HighHere's What Happened - MarketBeat

Dec 04, 2025

Dec 04, 2025

Nuvation Bio Inc. (NYSE:NUVB) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Dec 04, 2025

Dec 04, 2025

Will Nuvation Bio Inc. Class stock profit from AI boomJuly 2025 Selloffs & Trade Opportunity Analysis Reports - Newser

Dec 04, 2025

Dec 04, 2025

10 Stocks Stealing Market Spotlight - Insider Monkey

Dec 04, 2025

Dec 03, 2025

Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology - Investing News Network

Dec 03, 2025

Dec 03, 2025

Nuvation Bio’s Surge: Buy or Observe? - StocksToTrade

Dec 03, 2025

Dec 03, 2025

ETFs Investing in Nuvation Bio Inc. Stocks - TradingView

Dec 03, 2025

Dec 03, 2025

Nuvation Bio’s chief medical officer sells $1.17 million in stock - Investing.com

Dec 03, 2025

Dec 03, 2025

Nuvation Bio Insider Sold Shares Worth $1,173,255, According to a Recent SEC Filing - marketscreener.com

Dec 03, 2025

Dec 03, 2025

Nuvation Bio (NUVB) Chief Medical Officer reports 150K share sale and option exercise - Stock Titan

Dec 03, 2025

Dec 03, 2025

Nuvation Bio stock hits 52-week high at $8.24 - Investing.com

Dec 03, 2025

Dec 03, 2025

Nuvation Bio stock hits 52-week high at $8.24 By Investing.com - Investing.com Nigeria

Dec 03, 2025

Dec 03, 2025

NUVB: Iptrozi and Safusidenib show strong clinical and commercial momentum, driving major growth potential - TradingView

Dec 03, 2025

Dec 03, 2025

NUVB: Iptrozi and Safusidenib drive strong growth, with robust financials and pipeline innovation - TradingView

Dec 03, 2025

Dec 03, 2025

Nuvation Bio: Phase 2 study results in IDH1-mutant gliomas published - Traders Union

Dec 03, 2025

Dec 03, 2025

Will Nuvation Bio Inc. Warrants stock benefit from sector leadershipWeekly Loss Report & Real-Time Volume Analysis - Newser

Dec 03, 2025

Dec 03, 2025

Geode Capital Management LLC Acquires 864,194 Shares of Nuvation Bio Inc. $NUVB - MarketBeat

Dec 03, 2025

Dec 03, 2025

Will Nuvation Bio Inc. Class stock outperform benchmarks2025 Big Picture & Long-Term Growth Stock Strategies - Newser

Dec 03, 2025

Dec 02, 2025

Can Nuvation Bio Inc. Class stock surprise markets with earningsPortfolio Gains Summary & Stepwise Entry/Exit Trade Alerts - Newser

Dec 02, 2025

Dec 02, 2025

Is Nuvation Bio Inc. stock a safe buy before earningsTreasury Yields & AI Enhanced Market Trend Forecasts - Newser

Dec 02, 2025

Dec 01, 2025

Officer Liu Files To Sell 150,000 Of Nuvation Bio Inc [NUVB] - TradingView

Dec 01, 2025

Dec 01, 2025

H.C. Wainwright reiterates Buy rating on Nuvation Bio stock at $10 target By Investing.com - Investing.com South Africa

Dec 01, 2025

Dec 01, 2025

H.C. Wainwright reiterates Buy rating on Nuvation Bio stock at $10 target - Investing.com Canada

Dec 01, 2025

Dec 01, 2025

HC Wainwright & Co. Reiterates Nuvation Bio (NUVB) Buy Recommendation - Nasdaq

Dec 01, 2025

Dec 01, 2025

What is Wedbush's Estimate for Nuvation Bio FY2027 Earnings? - MarketBeat

Dec 01, 2025

Nov 30, 2025

Truist Financial Sticks to Their Buy Rating for Nuvation Bio (NUVB) - The Globe and Mail

Nov 30, 2025

Nov 30, 2025

Nuvation Bio’s Strategic Dilemma: Navigating Taletrectinib’s Global Commercialization Risks - MSN

Nov 30, 2025

Nov 29, 2025

Nuvation Bio: A Strong Company Now Fairly Priced - Seeking Alpha

Nov 29, 2025

Nov 28, 2025

Top Growth Companies With Strong Insider Ownership November 2025 - simplywall.st

Nov 28, 2025

Nov 28, 2025

Nuvation Bio (NUVB) Halts NUV-1511 and Highlights Safusidenib Data Is Strategic Focus Shifting? - Yahoo Finance

Nov 28, 2025

Nov 27, 2025

Nuvation Bio (NUVB): Exploring Valuation After a 52% One-Month Rally - Yahoo Finance

Nov 27, 2025

Nov 27, 2025

Insider Selling: Nuvation Bio (NYSE:NUVB) Insider Sells 10,000 Shares of Stock - MarketBeat

Nov 27, 2025

Nov 27, 2025

Nuvation Bio to discontinue development of NUV-1511 - MSN

Nov 27, 2025

Nov 27, 2025

Nuvation Bio to Participate in Upcoming December 2025 Investor Conferences - BioSpace

Nov 27, 2025